$19.85
-0.26-1.29%
At close: Dec 5, 4:00 PM EST
$19.80
-0.05-0.25%
After Hours: 4:10 PM EST
Comments
Loading...
ADMA Biologics Earnings Estimates, EPS & Revenue | NASDAQ:ADMA | Benzinga
ADMA Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 2
EPS Estimate
$0.190
Quarterly Revenue Estimate
$139.82M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$488.56M
Analyze the earnings history of ADMA Biologics using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ADMA | ADMA Biologics | $0.14 | $0.19 | — | — | $117.55M | $139.82M | — | — | 03/02/2026 | |
ADMA | ADMA Biologics | $0.15 | $0.16 | $0.16 | 0.00% | $119.84M | $130.36M | $134.22M | 2.96% | 11/05/2025 | |
ADMA | ADMA Biologics | $0.13 | $0.14 | $0.14 | 0.00% | $107.19M | $121.50M | $121.98M | 0.40% | 08/06/2025 | |
ADMA | ADMA Biologics | $0.08 | $0.14 | $0.14 | 0.00% | $81.88M | $116.40M | $114.80M | -1.37% | 05/07/2025 | |
ADMA | ADMA Biologics | $0.04 | $0.15 | $0.14 | -6.67% | $73.90M | $112.80M | $117.55M | 4.21% | 03/03/2025 | |
ADMA | ADMA Biologics | $0.01 | $0.13 | $0.15 | 15.38% | $67.28M | $105.85M | $119.84M | 13.22% | 11/07/2024 | |
ADMA | ADMA Biologics | -$0.03 | $0.08 | $0.13 | 62.50% | $60.12M | $86.41M | $107.19M | 24.05% | 08/08/2024 | |
ADMA | ADMA Biologics | -$0.03 | $0.05 | $0.08 | 60.00% | $56.91M | $77.27M | $81.88M | 5.96% | 05/09/2024 | |
ADMA | ADMA Biologics | -$0.06 | $0.02 | $0.04 | 100.00% | $49.98M | $72.15M | $73.90M | 2.43% | 02/28/2024 | |
ADMA | ADMA Biologics | -$0.08 | -$0.01 | $0.01 | 200.00% | $41.09M | $62.12M | $67.28M | 8.30% | 11/08/2023 | |
ADMA | ADMA Biologics | -$0.07 | -$0.02 | -$0.03 | -50.00% | $33.91M | $55.50M | $60.12M | 8.33% | 08/09/2023 | |
ADMA | ADMA Biologics | -$0.10 | -$0.04 | -$0.03 | 25.00% | $29.10M | $53.41M | $56.91M | 6.56% | 05/10/2023 | |
ADMA | ADMA Biologics | -$0.09 | -$0.06 | -$0.06 | 0.00% | $26.38M | $45.93M | $49.98M | 8.82% | 03/23/2023 | |
ADMA | ADMA Biologics | -$0.13 | -$0.08 | -$0.08 | 0.00% | $20.68M | $34.48M | $41.09M | 19.17% | 11/09/2022 | |
ADMA | ADMA Biologics | -$0.14 | -$0.08 | -$0.07 | 12.50% | $17.83M | $31.81M | $33.91M | 6.59% | 08/10/2022 | |
ADMA | ADMA Biologics | -$0.16 | -$0.08 | -$0.10 | -25.00% | $16.05M | $27.69M | $29.10M | 5.10% | 05/11/2022 | |
ADMA | ADMA Biologics | -$0.21 | -$0.09 | -$0.09 | 0.00% | $13.96M | $21.76M | $26.38M | 21.25% | 03/24/2022 | |
ADMA | ADMA Biologics | -$0.19 | -$0.14 | -$0.13 | 7.14% | $10.28M | $18.72M | $20.68M | 10.48% | 11/10/2021 | |
ADMA | ADMA Biologics | -$0.23 | -$0.15 | -$0.14 | 6.67% | $7.79M | $16.42M | $17.83M | 8.59% | 08/11/2021 | |
ADMA | ADMA Biologics | -$0.26 | -$0.17 | -$0.16 | 5.88% | $10.20M | $14.58M | $16.05M | 10.08% | 05/12/2021 | |
ADMA | ADMA Biologics | -$0.18 | -$0.16 | -$0.21 | -31.25% | $12.04M | $12.91M | $13.96M | 8.10% | 03/25/2021 |
ADMA Biologics (ADMA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $0.16 | $0.16 | 0.00 % |
| Q2 | 2025-08-06 | $0.14 | $0.14 | 0.00 % |
| Q1 | 2025-05-07 | $0.14 | $0.14 | 0.00 % |
| Q4 | 2025-03-03 | $0.14 | $0.15 | -6.67 % |
ADMA Biologics (ADMA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $134.22M | $130.36M | 2.96 % |
| Q2 | 2025-08-06 | $121.98M | $121.50M | 0.40 % |
| Q1 | 2025-05-07 | $114.80M | $116.40M | -1.37 % |
| Q4 | 2025-03-03 | $117.55M | $112.80M | 4.21 % |
FAQ
When is ADMA Biologics (NASDAQ:ADMA) reporting earnings?
ADMA Biologics (ADMA) is scheduled to report earnings on March 2, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
What were the latest earnings per share (EPS) for ADMA Biologics (NASDAQ:ADMA)?
The Actual EPS was $0.16, which hit the estimate of $0.16.
What were ADMA Biologics’s (NASDAQ:ADMA) revenues?
The Actual Revenue was $134.2M, which beat the estimate of $130.4M.
Browse earnings estimates, EPS, and revenue on all stocks.
